Tg Therapeutics (TGTX) Total Debt Growth (5y) (2015 - 2026)
Tg Therapeutics (TGTX) Total Debt Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Tg Therapeutics | 8.12 Bn | 8.05 Bn | 171.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.96% |
| Dec 31, 2025 | 52.38% |
| Sep 30, 2025 | 52.58% |
| Jun 30, 2025 | 52.78% |
| Mar 31, 2025 | 52.99% |
| Dec 31, 2024 | 53.19% |
| Sep 30, 2024 | 53.40% |
| Jun 30, 2024 | 29.17% |
| Mar 31, 2024 | 29.07% |
| Mar 31, 2021 | 187.67% |
| Dec 31, 2020 | 169.18% |
| Sep 30, 2020 | 177.07% |
| Jun 30, 2020 | 151.01% |
| Mar 31, 2020 | 154.74% |
| Dec 31, 2019 | 153.78% |
| Sep 30, 2019 | 174.88% |
| Mar 31, 2019 | 200.44% |
| Dec 31, 2015 | -57.97% |